133 related articles for article (PubMed ID: 4041555)
1. First-pass elimination of lidocaine in the rabbit after peroral and rectal route of administration.
Ritschel WA; Elconin H; Alcorn GJ; Denson DD
Biopharm Drug Dispos; 1985; 6(3):281-90. PubMed ID: 4041555
[TBL] [Abstract][Full Text] [Related]
2. Rectal bioavailability of lidocaine in man: partial avoidance of "first-pass" metabolism.
de Boer AG; Breimer DD; Mattie H; Pronk J; Gubbens-Stibbe JM
Clin Pharmacol Ther; 1979 Dec; 26(6):701-9. PubMed ID: 498711
[TBL] [Abstract][Full Text] [Related]
3. Rectal bioavailability of lidocaine in rats: absence of significant first-pass elimination.
de Boer AG; Breimer DD; Pronk J; Gubbens-Stibbe JM
J Pharm Sci; 1980 Jul; 69(7):804-7. PubMed ID: 7391945
[No Abstract] [Full Text] [Related]
4. Rectal bioavailability of lidocaine in the dog: evaluation of first-pass elimination.
Ritschel WA; Grummich KW; Hussain AS; Denson DD; Ritschel BE
Methods Find Exp Clin Pharmacol; 1987 Aug; 9(8):497-502. PubMed ID: 3695734
[TBL] [Abstract][Full Text] [Related]
5. Avoidance of "first-pass" elimination of rectally administered lidocaine in relation to the site of absorption in rats.
de Leede LG; de Boer AG; Roozen CP; Breimer DD
J Pharmacol Exp Ther; 1983 Apr; 225(1):181-5. PubMed ID: 6834271
[TBL] [Abstract][Full Text] [Related]
6. The rabbit as an experimental model for biopharmaceutical studies following rectal administration of theophylline.
Van Aerde P; Moerman E; Van Severen R; Braeckman P
Pharmazie; 1984 Mar; 39(3):171-2. PubMed ID: 6728890
[TBL] [Abstract][Full Text] [Related]
7. Some pharmacokinetic properties and bioavailability by oral and rectal route of piroxicam in rodents and in man.
Schiantarelli P; Acerbi D; Bovis G
Arzneimittelforschung; 1981; 31(1):92-7. PubMed ID: 6971114
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of hydromorphone after intravenous, peroral and rectal administration to human subjects.
Parab PV; Ritschel WA; Coyle DE; Gregg RV; Denson DD
Biopharm Drug Dispos; 1988; 9(2):187-99. PubMed ID: 2453226
[TBL] [Abstract][Full Text] [Related]
9. Oral and rectal nalbuphine bioavailability: first-pass metabolism in rats and dogs.
Aungst BJ; Lam G; Shefter E
Biopharm Drug Dispos; 1985; 6(4):413-21. PubMed ID: 4084666
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
[TBL] [Abstract][Full Text] [Related]
11. Avoidance of hepatic first-pass effect in the rabbit via rectal route of administration.
Kurosawa N; Owada E; Ito K
Biopharm Drug Dispos; 1998 Dec; 19(9):589-94. PubMed ID: 9872341
[TBL] [Abstract][Full Text] [Related]
12. Absolute bioavailability of hydromorphone after peroral and rectal administration in humans: saliva/plasma ratio and clinical effects.
Ritschel WA; Parab PV; Denson DD; Coyle DE; Gregg RV
J Clin Pharmacol; 1987 Sep; 27(9):647-53. PubMed ID: 2445789
[TBL] [Abstract][Full Text] [Related]
13. On the pharmacokinetics of domperidone in animals and man. IV. The pharmacokinetics of intravenous domperidone and its bioavailability in man following intramuscular, oral and rectal administration.
Heykants J; Hendriks R; Meuldermans W; Michiels M; Scheygrond H; Reyntjens H
Eur J Drug Metab Pharmacokinet; 1981; 6(1):61-70. PubMed ID: 7250152
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and relative bioavailability of vinylbital in man after oral and rectal administration.
Breimer DD; de Boer AG
Arzneimittelforschung; 1976; 26(3):448-54. PubMed ID: 989344
[TBL] [Abstract][Full Text] [Related]
15. Enhanced absorption of bumetanide from suppositories containing weak acids in rabbits.
Yagi N; Kenmotsu H; Shimode Y; Oda K; Sekikawa H; Takada M
Biol Pharm Bull; 1993 Mar; 16(3):263-7. PubMed ID: 8364470
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and bioavailability of papaverine HCl following intravenous, peroral, rectal, vaginal, topical and buccal administration in beagle dogs.
Kraus C; Shaaya A; Ulmer J; Hutchings D; Menon A; Sakr A; Ritschel WA
Biopharm Drug Dispos; 1991 Oct; 12(7):537-46. PubMed ID: 1932615
[TBL] [Abstract][Full Text] [Related]
17. Reduction of oral bioavailability of lignocaine by induction of first pass metabolism in epileptic patients.
Perucca E; Richens A
Br J Clin Pharmacol; 1979 Jul; 8(1):21-31. PubMed ID: 552293
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of the antidepressant levoprotiline after intravenous and peroral administration in healthy volunteers.
Kaiser G; Ackermann R; Dieterle W; Reimann IW; Bieck PR
Biopharm Drug Dispos; 1992 Mar; 13(2):83-93. PubMed ID: 1550911
[TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of suppositories for RK-28 (a new radiosensitizer) using rabbits.
Kim NS; Umejima H; Miyata K; Okubo M; Goto S; Kato T; Mikami Y; Sagitani H; Inoue H
Biol Pharm Bull; 1994 May; 17(5):672-5. PubMed ID: 7920431
[TBL] [Abstract][Full Text] [Related]
20. Pilot study on bioavailability of coumarin and 7-hydroxycoumarin upon peroral administration of coumarin in a sustained-release dosage form.
Ritschel WA; Hoffmann KA
J Clin Pharmacol; 1981 Jul; 21(7):294-300. PubMed ID: 7263928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
